|
Match
|
Document |
Document Title |
|
|
US20150086627 |
DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE
Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage forms, for administration to subjects... |
|
|
US20120082721 |
Enteric coating
The present invention refers to a dosage form comprising an enteric coating in a specific amount, and to the use of enteric coating compositions for preparing a dosage form. Furthermore, the... |
|
|
US20120189693 |
ORAL DOSAGE FORMS
Aspects of the present invention are directed to oral dosage forms comprising a compressed microtablet, wherein said microtablet has a major dimension that is between about 0.25 mm and about 1.0... |
|
|
US20110008412 |
Oral Formulations for 5-HT-Receptor Agonists, Uses and Methods of Treatment Employing The Same
A pharmaceutically acceptable oral formulation comprising core material which comprises a therapeutically effective amount of a 5-HT-receptor agonist, or a pharmaceutically acceptable salt,... |
|
|
US20140341963 |
Device for the Treatment of Bone Conditions
A composition comprising at least one substance coated with an agent wherein the agent forms a liquid impermeable but gas permeable layer surrounding the said substance and preventing the passage... |
|
|
US20140154318 |
LOTION TABLET THAT PROVIDES OXYGEN
There is provided a lotion tablet for the delivery of oxygen having an outer layer or “crust” coating an interior, that liberates oxygen upon rupture of the crust. The oxygen may be generated in... |
|
|
US20130122092 |
THREE-PHASE CONTROLLED-RELEASE TABLET COMPRISING MELATONIN AND PROCESS OF PREPARATION
The invention relates, in one aspect, to a tablet having an internal core and external coating, both comprising melatonin and separated by an internal coating which does not comprise melatonin.... |
|
|
US20090252794 |
TABLET
The present invention provides a novel tablet with improved tablet appearance and improved swallowability. The tablet contains a pharmaceutically acceptable anion exchange resin represented by... |
|
|
US20090274757 |
PHARMACEUTICAL POLISH FORMULATIONS
Polish compositions for coating pharmaceutical solid dosage forms such as tablets are disclosed. The polish composition comprises water, coating agent, and a film forming agent. Polished... |
|
|
US20100074949 |
Pharmaceutical composition and administration thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4
-oxoquinoline-3-carboxamide, methods of... |
|
|
US20100068274 |
PROCESS FOR PRODUCTION OF TABLET
An object of the present invention is to provide a dry coating method which can coat a tablet in a simple manner and with high efficiency, and therefore can produce a tablet having good appearance... |
|
|
US20100074951 |
CONTROLLED RELEASE COMPLEX COMPOSITION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKERS AND HMG-COA REDUCTASE INHIBITORS
Disclosed herein is a lag time delayed-release combination pharmaceutical composition comprising of an angiotensin-II-receptor blocker and an HMG-CoA reductase inhibitor, as well as a preparation... |
|
|
US20140112988 |
Pharmaceutical Composition and Administrations Thereof
The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4
-oxoquinoline-3-carboxamide, methods of... |
|
|
US20110280942 |
FILM COATING COMPOSITION AND METHODS OF MAKING AND USING THE SAME
A film coating composition comprising a cellulosic polymer, an opacifying agent, and a fatty acid is disclosed herein. Also disclosed is a film coating composition comprising a cellulosic polymer,... |
|
|
US20130251794 |
Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
The present invention relates to a method for “hot melt coating” of pharmaceutical active ingredients characterized by organoleptic or physicochemical properties that it is desirable to mask. The... |
|
|
US20080014271 |
NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING LEVETIRACETAM
The present invention relates to pharmaceutical compositions comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation. |
|
|
US20080050432 |
Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
The present invention relates to a combined pharmaceutical formulation, which is such designed that the release of each ingredient may be controlled to a predetermined release rate by applying the... |
|
|
US20100203134 |
SPHEROIDS AND MULTIPARTICULATE TABLETS COMPRISING THEM
The invention relates to a directly-compressible gastro-resistant spheroid. The spheroid comprises: (i) a core containing one or more active substances; (ii) a flexible, deformable film which... |
|
|
US20100159003 |
PROCESS FOR THE PREPARATION OF A MEDICAMENT COMPRISING VARDENAFIL HYDROCHLORIDE TRIHYDRATE
The present invention relates to a process for the preparation of a medicament containing vardenafil hydrochloride trihydrate in solid form, in which vardenafil hydrochloride trihydrate is... |
|
|
US20160058709 |
PLURIMODAL RELEASE FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF
A solid oral dosage form comprising a core comprising a doxylamine component and a pyridoxine component coated with an enteric coating is disclosed. The solid oral dosage form further comprises... |
|
|
US20150328166 |
Device for the Treatment of Bone Conditions
A composition comprising at least one substance coated with an agent wherein the agent forms a liquid impermeable but gas permeable layer surrounding the said substance and preventing the passage... |